INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2016

In utero arsenic exposure was linked to a higher risk of infant infections and respiratory symptoms during the first year of life in a U.S. cohort.

In a prospective study of 412 infants followed at 4, 8, and 12 months, researchers examined associations between maternal pregnancy urinary arsenic and infant infections and symptoms over the first year. Each doubling of maternal urinary arsenic was related to an increase in total infections requiring prescription medication (RR = 1.1; 95% CI: 1.0, 1.2). Urinary arsenic was also related to respiratory symptoms lasting ≥ 2 days (RR = 1.1; 95% CI: 1.0, 1.2) or requiring prescription medication (RR = 1.2; 95% CI: 1.0, 1.5), and to wheezing lasting ≥ 2 days, resulting in a doctor visit, or prescription medication treatment (RR = 1.3, RR = 1.3, and RR = 1.5, respectively). Associations were also observed with diarrhea (RR = 1.4; 95% CI: 1.1, 1.9) and fever resulting in a doctor visit (RR = 1.2; 95% CI: 1.0, 1.5).

Shows an association, not proof of cause and effect.

Study type
Prospective cohort study
Who was studied
412 infants and their mothers in a U.S. study area
What was measured
Infant infections and respiratory symptoms over the first year of life

THE PAPER

Infant Infections and Respiratory Symptoms in Relation to in Utero Arsenic Exposure in a U.S. Cohort.

Farzan SF, Li Z, Korrick SA, Spiegelman D, Enelow R, Nadeau K, Baker E, Karagas MR. Environ Health Perspect, 2016.

PubMed 26359651 ↗DOI 10.1289/ehp.8832 ↗

Food safety & contaminantsOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.